THE DE PARYS GROUP
DE PARYS GROUP, 23 DE PARYS AVENUE, BEDFORD
AF 6
In those patients with Atrial Fibrillation in whom there is a record of a CHADS2 score of 1, the percentage of patients who are currently treated with anti-coagulation drug therapy or an anti-platelet therapy.
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| AF 6 | 2013 | 61 | 65 | 93.8% | |
| AF003 | 2014 | 60 | 61 | 98.4% | |
| AF005 | 2015 | 64 | 65 | 98.5% | |
| AF007 | 2016 | 239 | 278 | 86.0% | |
| AF007 | 2017 | 269 | 299 | 90.0% | |
| AF007 | 2018 | 319 | 341 | 93.5% | |
| AF007 | 2019 | 799 | 805 | 99.3% | |
| AF007 | 2020 | 805 | 812 | 99.1% | |
| AF007 | 2021 | 791 | 795 | 99.5% | |
| AF007 | 2022 | 744 | 790 | 94.2% | |
| AF007 | 2023 | 775 | 792 | 97.9% |
